We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+5.5%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.72B
AUM Growth
-$277M
Cap. Flow
-$598M
Cap. Flow %
-7.74%
Top 10 Hldgs %
14.2%
Holding
2,837
New
108
Increased
534
Reduced
1,798
Closed
392

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$32M
2
MSFT icon
Microsoft
MSFT
+$15.3M
3
GILD icon
Gilead Sciences
GILD
+$12.4M
4
AMGN icon
Amgen
AMGN
+$10.3M
5
CELG
Celgene Corp
CELG
+$9.92M

Sector Composition

Rank Sector Weight
1 Financials 17.01%
2 Technology 15.04%
3 Healthcare 13.56%
4 Industrials 9.01%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWBO
2326
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$116K ﹤0.01%
+17,317
New +$110K
LEE icon
2327
Lee Enterprises
LEE
$166M
$115K ﹤0.01%
+2,580
New +$108K
AOI
2328
DELISTED
Alliance One International
AOI
$114K ﹤0.01%
4,572
-4,469
-49% -$118K
CORR
2329
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$113K ﹤0.01%
+3,046
New +$108K
CYTR
2330
DELISTED
CytRx Corp
CYTR
$113K ﹤0.01%
+4,491
New +$102K
CASC
2331
DELISTED
Cascadian Therapeutics, Inc.
CASC
$112K ﹤0.01%
+5,746
New +$101K
MHGC
2332
DELISTED
Morgans Hotel Group Co.
MHGC
$112K ﹤0.01%
14,109
-12,843
-48% -$99.6K
KOPN icon
2333
Kopin
KOPN
$663M
$111K ﹤0.01%
34,183
-34,205
-50% -$113K
POZN
2334
DELISTED
POZEN INC
POZN
$111K ﹤0.01%
13,317
-13,961
-51% -$120K
SWS
2335
DELISTED
SWS GROUP INC
SWS
$111K ﹤0.01%
15,261
-14,632
-49% -$108K
SZMK
2336
DELISTED
SIZMEK INC COM STK (DE)
SZMK
$110K ﹤0.01%
11,530
-13,439
-54% -$132K
BPTH
2337
DELISTED
Bio-Path Holdings Inc
BPTH
$109K ﹤0.01%
+9
New +$98.6K
PKT
2338
DELISTED
PROCERA NETWORKS INC NEW COM STK (DE)
PKT
$109K ﹤0.01%
10,789
-10,447
-49% -$99.2K
NAVB
2339
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$108K ﹤0.01%
3,663
-2,390
-39% -$77.3K
ACLS icon
2340
Axcelis
ACLS
$4.12B
$107K ﹤0.01%
13,384
-14,004
-51% -$104K
FLNA
2341
Filana Therapeutics
FLNA
$43M
$107K ﹤0.01%
+2,648
New +$98K
TGTX icon
2342
TG Therapeutics
TGTX
$8.58B
$107K ﹤0.01%
11,442
-4,296
-27% -$27.5K
GEG icon
2343
Great Elm Group
GEG
$68.4M
$106K ﹤0.01%
3,979
-4,359
-52% -$112K
RDNT icon
2344
RadNet
RDNT
$4.84B
$106K ﹤0.01%
+15,923
New +$91.5K
BIRT
2345
DELISTED
Actuate Corp
BIRT
$106K ﹤0.01%
22,173
-25,730
-54% -$126K
CCRN
2346
DELISTED
Cross Country Healthcare
CCRN
$105K ﹤0.01%
16,059
-11,959
-43% -$79.1K
POWR
2347
DELISTED
POWERSECURE INTL INC COM STK (DE)
POWR
$105K ﹤0.01%
10,766
-11,127
-51% -$152K
PGEM
2348
DELISTED
Ply Gem Holdings, Inc.
PGEM
$105K ﹤0.01%
10,387
-5,604
-35% -$66.6K
ALR
2349
DELISTED
AlerisLife Inc
ALR
$104K ﹤0.01%
2,071
-2,265
-52% -$112K
RNDY
2350
DELISTED
ROUNDYS INC COM STK
RNDY
$104K ﹤0.01%
18,900
-8,904
-32% -$52.2K

Similar funds

ProShare Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, ProShare Advisors held 2,837 positions worth $7.72B, down 3.5% from $8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

ProShare Advisors withdrew a net $598M in Q2 2014, closing 392 positions and reducing 1,798 holdings. Its most notable exit was CoStar Group, an estimated $5.45M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, ProShare Advisors opened a new position in Navient worth $3.44M.

  • ProShare Advisors's largest Q2 2014 buy was Navient: 194,061 shares worth $3.44M.
  • ProShare Advisors added most to Affiliated Managers Group in Q2 2014, an estimated $3.87M increase.
  • ProShare Advisors's biggest Q2 2014 reduction was Apple, cutting an estimated $32M.
  • ProShare Advisors fully exited CoStar Group in Q2 2014, selling an estimated $5.45M.
  • ProShare Advisors's ten largest holdings make up 14% of its $7.72B portfolio in Q2 2014.
  • ProShare Advisors opened 108 new positions and closed 392 in Q2 2014.
  • ProShare Advisors's portfolio value fell 3.5% quarter-over-quarter to $7.72B.

Based on ProShare Advisors's 13F filing for Q2 2014, filed 8 Aug 2014.